{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-28",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 17902
    }
  },
  "results": [
    {
      "safetyreportversion": "2",
      "safetyreportid": "10007415",
      "primarysourcecountry": "GR",
      "occurcountry": "GR",
      "transmissiondateformat": "102",
      "transmissiondate": "20141002",
      "reporttype": "2",
      "serious": "1",
      "seriousnessdeath": "1",
      "receivedateformat": "102",
      "receivedate": "20140313",
      "receiptdateformat": "102",
      "receiptdate": "20140320",
      "fulfillexpeditecriteria": "1",
      "companynumb": "GR-GLAXOSMITHKLINE-B0976186A",
      "duplicate": "1",
      "reportduplicate": {
        "duplicatesource": "GLAXOSMITHKLINE",
        "duplicatenumb": "GR-GLAXOSMITHKLINE-B0976186A"
      },
      "primarysource": {
        "reportercountry": "GR",
        "qualification": "1"
      },
      "sender": {
        "sendertype": "2",
        "senderorganization": "FDA-Public Use"
      },
      "receiver": {
        "receivertype": "6",
        "receiverorganization": "FDA"
      },
      "patient": {
        "patientonsetage": "34",
        "patientonsetageunit": "801",
        "patientweight": "45",
        "patientsex": "2",
        "reaction": [
          {
            "reactionmeddraversionpt": "17.0",
            "reactionmeddrapt": "Multi-organ failure",
            "reactionoutcome": "5"
          }
        ],
        "drug": [
          {
            "drugcharacterization": "1",
            "medicinalproduct": "ZANAMIVIR",
            "drugauthorizationnumb": "021036",
            "drugstructuredosagenumb": "600",
            "drugstructuredosageunit": "003",
            "drugseparatedosagenumb": "2",
            "drugintervaldosageunitnumb": "1",
            "drugintervaldosagedefinition": "804",
            "drugdosagetext": "600MG TWICE PER DAY",
            "drugdosageform": "INJECTION",
            "drugadministrationroute": "042",
            "drugindication": "H1N1 INFLUENZA",
            "drugstartdateformat": "102",
            "drugstartdate": "20140226",
            "drugenddateformat": "102",
            "drugenddate": "20140302",
            "actiondrug": "1",
            "openfda": {
              "application_number": [
                "NDA021036"
              ],
              "brand_name": [
                "RELENZA"
              ],
              "generic_name": [
                "ZANAMIVIR"
              ],
              "manufacturer_name": [
                "GlaxoSmithKline LLC"
              ],
              "product_ndc": [
                "0173-0681"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "RESPIRATORY (INHALATION)"
              ],
              "substance_name": [
                "ZANAMIVIR"
              ],
              "rxcui": [
                "759471",
                "759473"
              ],
              "spl_id": [
                "244881b7-a19f-4409-abf7-2df6ad39c28e"
              ],
              "spl_set_id": [
                "d7c3bcc3-0c0d-4068-fd80-88cf54a376ef"
              ],
              "package_ndc": [
                "0173-0681-01",
                "0173-0681-22"
              ],
              "nui": [
                "N0000175524",
                "N0000175436"
              ],
              "pharm_class_epc": [
                "Neuraminidase Inhibitor [EPC]"
              ],
              "pharm_class_moa": [
                "Neuraminidase Inhibitors [MoA]"
              ],
              "unii": [
                "L6O3XI777I"
              ]
            }
          },
          {
            "drugcharacterization": "2",
            "medicinalproduct": "TAMIFLU",
            "drugstartdateformat": "102",
            "drugstartdate": "20140225",
            "drugenddateformat": "102",
            "drugenddate": "20140226",
            "actiondrug": "5",
            "openfda": {
              "application_number": [
                "NDA021087",
                "NDA021246"
              ],
              "brand_name": [
                "TAMIFLU"
              ],
              "generic_name": [
                "OSELTAMIVIR PHOSPHATE"
              ],
              "manufacturer_name": [
                "Genentech, Inc."
              ],
              "product_ndc": [
                "0004-0800",
                "0004-0802",
                "0004-0801",
                "0004-0822"
              ],
              "product_type": [
                "HUMAN PRESCRIPTION DRUG"
              ],
              "route": [
                "ORAL"
              ],
              "substance_name": [
                "OSELTAMIVIR PHOSPHATE"
              ],
              "rxcui": [
                "261315",
                "312122",
                "728109",
                "728111",
                "728113",
                "728115",
                "1115698",
                "1115700"
              ],
              "spl_id": [
                "94a312ac-c47a-4437-8dd3-6bcd7e08e42c"
              ],
              "spl_set_id": [
                "ee3c9555-60f2-4f82-a760-11983c86e97b"
              ],
              "package_ndc": [
                "0004-0802-85",
                "0004-0801-85",
                "0004-0800-85",
                "0004-0800-07",
                "0004-0800-08",
                "0004-0822-05"
              ],
              "unii": [
                "4A3O49NGEZ"
              ]
            }
          }
        ]
      }
    }
  ]
}